ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 555,90
-0,53%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Surface Oncology Inc (SURF)

  7. Surface Oncology Inc (SURF) Actualités

SURF Surface Oncology Inc

1,07
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Surface Oncology Inc SURF NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,07 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,07 1,07
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/9/202322:10EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/9/202322:04EDGAR2Form POS AM - Post-Effective amendments for registration..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202315:21EDGAR2Form 8-K - Current report
31/8/202323:18EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/8/202322:01GLOBESurface Oncology Announces ISS and Glass Lewis Both..
30/8/202322:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/8/202322:32EDGAR2Form 425 - Prospectuses and communications, business..
30/8/202322:31EDGAR2Form 8-K - Current report
12/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:00EDGAR2Form 8-K - Current report
02/8/202313:00GLOBESurface Oncology Reports Financial Results and Corporate..
26/7/202322:56EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
20/7/202314:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/7/202323:08EDGAR2Form 425 - Prospectuses and communications, business..
12/7/202323:05EDGAR2Form 425 - Prospectuses and communications, business..
08/7/202303:39EDGAR2Form 8-K - Current report
03/7/202322:01EDGAR2Form 8-K - Current report
16/6/202313:01GLOBECoherus to Acquire Surface Oncology

Dernières Valeurs Consultées

NASDAQ
SURF
Surface Oncology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés